Skip to main content

Find Clinical Trials

Home
Conditions
T-ALL/Lymphoma

Clinical trial condition

T-ALL/Lymphoma

Explore clinical trials studying T-ALL/Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

T-ALL/Lymphoma trial results

Recruiting

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

NCT06911710

Conditions: AML (Acute Myelogenous Leukemia), B-ALL, Blood Protein Disorders, +23 more
Locations: TianJin China. TianJin Medical University General Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

NCT06909474

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China

View Trial Details